rs201155045
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_032638.5(GATA2):c.1286G>C(p.Ser429Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000173 in 1,614,238 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S429N) has been classified as Uncertain significance.
Frequency
Consequence
NM_032638.5 missense
Scores
Clinical Significance
Conservation
Publications
- deafness-lymphedema-leukemia syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
 - GATA2 deficiency with susceptibility to MDS/AMLInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
 - monocytopenia with susceptibility to infectionsInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
 - acute myeloid leukemiaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
 - myelodysplastic syndromeInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
 
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| GATA2 | NM_032638.5  | c.1286G>C | p.Ser429Thr | missense_variant | Exon 6 of 6 | ENST00000341105.7 | NP_116027.2 | |
| GATA2 | NM_001145661.2  | c.1286G>C | p.Ser429Thr | missense_variant | Exon 7 of 7 | NP_001139133.1 | ||
| GATA2 | NM_001145662.1  | c.1244G>C | p.Ser415Thr | missense_variant | Exon 6 of 6 | NP_001139134.1 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000328  AC: 5AN: 152228Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.0000795  AC: 20AN: 251460 AF XY:  0.0000441   show subpopulations 
GnomAD4 exome  AF:  0.0000157  AC: 23AN: 1461892Hom.:  0  Cov.: 31 AF XY:  0.0000124  AC XY: 9AN XY: 727248 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.0000328  AC: 5AN: 152346Hom.:  0  Cov.: 33 AF XY:  0.0000134  AC XY: 1AN XY: 74498 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
- -
Deafness-lymphedema-leukemia syndrome    Uncertain:1 
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Acute myeloid leukemia;C3279664:Deafness-lymphedema-leukemia syndrome;C3280030:Monocytopenia with susceptibility to infections;C3463824:Myelodysplastic syndrome    Uncertain:1 
- -
not provided    Uncertain:1 
In silico analysis supports that this missense variant does not alter protein structure/function; Observed in an adult with acute myeloid leukemia; however, it is unclear if the variant was germline or somatic (PMID: 30190467); This variant is associated with the following publications: (PMID: 31340620, 30190467) -
Acute myeloid leukemia    Uncertain:1 
- -
Deafness-lymphedema-leukemia syndrome;CN300066:GATA2 deficiency with susceptibility to MDS/AML    Uncertain:1 
No criteria satisfied -
Inborn genetic diseases    Benign:1 
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Deafness-lymphedema-leukemia syndrome;C3280030:Monocytopenia with susceptibility to infections    Benign:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at